Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Peter Barrett


  • Director at Perkinelmer Inc (PKI), 2017-11-14
  • Director at Synlogic Inc. (SYBX), 2017-08-30
  • Large Shareholder, Director at Zafgen Inc. (ZFGN), 2017-06-23
  • Director at Vitae Pharmaceuticals Inc (VTAE), 2014-10-01
  • Director at Sciclone Pharmaceuticals Inc (SCLN), 2012-06-11
  • Large Shareholder, Director at Helicos Biosciences Corp (HLCS), 2009-09-22
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
VTAE $8.00 37,500 Director 1,174,315 2014-09-29 Filing
HLCS $0.00 242,931 Large Shareholder, Director 11,851,387 2009-09-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PKI $71.07 7,071 Director 19,200 2017-11-13 Filing
PKI $63.22 10,000 Director 19,200 2017-06-01 Filing